Evidence map›Paper›PMID 27899364›Full record

ArticleJournal of the American Heart Association2016

Identification of Shared and Unique Serum Lipid Profiles in Diabetes Mellitus and Myocardial Infarction.

Sanela Kjellqvist, Christian Klose, Michal A Surma, George Hindy, Inês G Mollet, Anna Johansson, Patrick Chavaux, Johan Gottfries, Kai Simons, Olle Melander and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Sanela KjellqvistScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Christian KloseLipotype GmbH, Dresden, Germany.
Michal A SurmaLipotype GmbH, Dresden, Germany.
George HindyDepartment of Clinical Sciences, Lund University, Malmö, Sweden.
Inês G MolletDepartment of Clinical Sciences, Lund University, Malmö, Sweden.
Anna JohanssonScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Patrick ChavauxDepartment of Nutrition, Faculté de Médecine et de Pharmacie de la Timone, Aix Marseille University, Marseille, France.
Johan GottfriesDepartment of Chemistry and Molecular Biology, University of Gothenburg, Sweden.
Kai SimonsLipotype GmbH, Dresden, Germany.
Olle MelanderDepartment of Clinical Sciences, Lund University, Malmö, Sweden.
Céline FernandezDepartment of Clinical Sciences, Lund University, Malmö, Sweden celine.fernandez@med.lu.se.
Lund University · SEGenotype (Germany) · DEAix-Marseille Université · FRScience for Life Laboratory · SEStockholm University · SEUniversity of Gothenburg · SE

Funding

European Research Council 282255
6 · The paper itself

Abstract

backgroundDiabetes mellitus (DM) and cardiovascular disease are associated with dyslipidemia, but the detailed lipid molecular pattern in both diseases remains unknown. METHODS AND

resultsWe used shotgun mass spectrometry to determine serum levels of 255 molecular lipids in 316 controls, 171 DM, and 99 myocardial infarction (MI) events from a cohort derived from the Malmö Diet and Cancer study. Orthogonal projections to latent structures analyses were conducted between the lipids and clinical parameters describing DM or MI. Fatty acid desaturases (FADS) and elongation of very long chain fatty acid protein 5 (ELOVL5) activities were estimated by calculating product to precursor ratios of polyunsaturated fatty acids in complex lipids. FADS genotypes encoding these desaturases were then tested for association with lipid levels and ratios. Differences in the levels of lipids belonging to the phosphatidylcholine and triacylglyceride (TAG) classes contributed the most to separating DM from controls. TAGs also played a dominating role in discriminating MI from controls. Levels of C18:2 fatty acids in complex lipids were lower both in DM and MI versus controls (DM, P=0.004; MI, P=6.0E-06) at least due to an acceleration in the metabolic flux from C18:2 to C20:4 (eg, increased estimated ELOVL5: DM, P=0.02; MI, P=0.04, and combined elongase-desaturase activities: DM, P=3.0E-06; MI, P=2.0E-06). Minor allele carriers of FADS genotypes were associated with increased levels of C18:2 (P≤0.007) and lower desaturase activity (P≤0.002).

conclusionsWe demonstrate a possible relationship between decreased levels of C18:2 in complex lipids and DM or MI. We thereby highlight the importance of molecular lipids in the pathogenesis of both diseases.

Indexed as

AcetyltransferasesAgedCase-Control StudiesDiabetes Mellitus, Type 2Fatty Acid DesaturasesFatty Acid ElongasesFatty Acids, UnsaturatedFemaleGenotypeHumansLipid MetabolismMaleMass SpectrometryMiddle AgedMyocardial InfarctionPolymorphism, Single NucleotideAcetyltransferasesELOVL5 protein, humanFatty Acid DesaturasesFatty Acid ElongasesFatty Acids, Unsaturateddiabetes mellitusfatty acid desaturasegenotypelipid metabolitesmyocardial infarction

Identifiers

PMID27899364
PMCPMC5210412
OpenAlexW2559274342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.